NCT06143631View on ClinicalTrials.gov

Prescription of Letrozole for Uterine Myoma

PHASE4RecruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

July 24, 2024

Primary Completion Date

January 30, 2027

Study Completion Date

April 30, 2027

Conditions
Leiomyoma, UterineLeiomyomaFibroidFibroid Uterus
Interventions
DRUG

Letrozole 2.5mg

Oral letrozole 2.5mg/day

OTHER

Placebo

Placebo capsule

Trial Locations (2)

39216

RECRUITING

University of Mississippi Medical Center, Jackson

94115

RECRUITING

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

University of California, San Francisco

OTHER